Related Experiment Video
Updated: Jul 23, 2025
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
12.5K
Structure-function relationship of new peptides activating human Nav1.1.
Ludivine Lopez1, Stephan De Waard2, Hervé Meudal3
1Nantes Université, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France; Smartox Biotechnology, Saint-Egrève, France.
Summary
Researchers identified JzTx-34, a peptide that activates the Nav1.1 channel, offering potential for treating neurological and cardiac conditions caused by reduced channel function.
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- Nav1.1 channels are crucial drug targets for neurological and cardiac disorders.
- Channel activators are needed to address haploinsufficiency in these conditions.
Purpose of the Study:
- To discover novel peptide compounds that activate Nav1.1 channels.
- To investigate the structure-activity relationship of identified peptides to understand their mechanism of action.
Main Methods:
- Screening of natural peptide sources for ion channel activity.
- Structure-activity relationship studies of JzTx-34 on Nav1.1.
- Analysis of structural determinants for peptide synthesis.
Main Results:
- JzTx-34 was identified as a potent activator of Nav1.1 channels.
- The pharmacophore of JzTx-34 was elucidated through structure-activity relationship studies.
- Structural challenges in synthesizing natural ICK peptides targeting Nav1.1 were revealed.
Conclusions:
- JzTx-34 represents a promising lead compound for Nav1.1-related channelopathies.
- Understanding the structure-activity relationships facilitates the development of new therapeutic peptides.
- This research aids in the discovery and development of novel compounds for critical ion channel targets.
Related Concept Videos
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
01:15Cholinergic Receptors: Nicotinic
2.9K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.9K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608